Antigen presenting cells of lower airways in interstitial lung diseases (ILD). Do alveolar lymphocytes possess the ability to present antigens?

P. Kopinski, J. Szczeklik, J. Chorostowska-Wynimko, B. Balicka-Slusarczyk, A. Szpechcinski, G. Przybylski, A. Jarzemska, E. Polgesek (Bygoszcz-Torun, Krakow, Warszawa, Bydgoszcz-Torun, Poland)

Source: Annual Congress 2010 - Clinical issues in diffuse parenchymal lung disease
Session: Clinical issues in diffuse parenchymal lung disease
Session type: Thematic Poster Session
Number: 837
Disease area: Interstitial lung diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
P. Kopinski, J. Szczeklik, J. Chorostowska-Wynimko, B. Balicka-Slusarczyk, A. Szpechcinski, G. Przybylski, A. Jarzemska, E. Polgesek (Bygoszcz-Torun, Krakow, Warszawa, Bydgoszcz-Torun, Poland). Antigen presenting cells of lower airways in interstitial lung diseases (ILD). Do alveolar lymphocytes possess the ability to present antigens?. Eur Respir J 2010; 36: Suppl. 54, 837

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Differences in alveolar cell populations, natural killer cells and lymphocyte subsets between pulmonary sarcoidosis (PS) and idiopathic pulmonary fibrosis (IPF)
Source: Eur Respir J 2006; 28: Suppl. 50, 745s
Year: 2006

Immunohistochemical analysis of T lymphocytes (TLs) in lung tissue from patients with idiopathic pulmonary fibrosis (IPF) suggests potential role of CD8+ TLs in lung injury
Source: Eur Respir J 2004; 24: Suppl. 48, 46s
Year: 2004

aEb7 integrin (CD103-b7) expression in bronchoalveolar T lymphocytes in interstitial lung diseases
Source: Eur Respir J 2007; 30: Suppl. 51, 576s
Year: 2007

The role of macrophages in interstitial lung diseases
Source: Eur Respir Rev, 26 (145) 170009; 10.1183/16000617.0009-2017
Year: 2017



TNFα and INFγ inducing capacity of sera from interstitial lung diseases (ILD) patients in relation to its angiogenic activity
Source: Eur Respir J 2001; 18: Suppl. 33, 410s
Year: 2001

Airway dendritic cell phenotypes in inflammatory diseases of the human lung
Source: Eur Respir J 2007; 30: 878-886
Year: 2007



A high probability of short-range interactions between fibrocytes and CD8+ T cells potentiates the inflammatory response in chronic obstructive pulmonary disease (COPD) lungs
Source: Virtual Congress 2020 – Host-microbe interactions and their influence on lung disease onset and severity
Year: 2020


Cytokine and chemokine release in response to Pseudomonas aeruginosa (PA), by bronchial epithelium of the native airway and transplanted lung of paediatric cystic fibrosis (CF) lung transplant recipients
Source: Annual Congress 2012 - Cystic fibrosis (adults and children): new basic and clinical physiology research
Year: 2012


Alveolar lymphocytes (AL) apoptosis in interstitial lung diseases (ILD). Increased AL apoptosis rate in idiopathic pulmonary fibrosis (IPF)
Source: Annual Congress 2009 - Pathogenesis of pulmonary fibrosis
Year: 2009


Subpopulation analysis of peripheral blood lymphocytes in different variants of exogenic allergic alveolitis (EAA)
Source: Annual Congress 2013 –Sarcoidosis and other granulomatosis
Year: 2013


Dendritic cells and the immunological homeostasis of the lung
Source: Annual Congress 2006 - A new look at dendritic cell interactions in the lung
Year: 2006


Increased expression of SARS-CoV-2 (Covid-19) adhesion sites on type II pneumocytes, small airway epithelium, and alveolar macrophages in smokers and patients with COPD
Source: Virtual Congress 2021 – Mechanistic pathways in chronic and new lung diseases
Year: 2021



CD8+ T-cell alveolitis in familial pulmonary alveolar microlithiasis
Source: Eur Respir J 2007; 30: 165-171
Year: 2007



Cytotoxic lymphocytes in different interstitial lung diseases
Source: Eur Respir J 2003; 22: Suppl. 45, 226s
Year: 2003

Phenotype of dendritic cells (DCs) stimulated by microbial antigens in COPD patients with frequent and infrequent exacerbations.
Source: International Congress 2017 – Infection and exacerbation science
Year: 2017

Decreased small airway and alveolar mature dendritic cells in chronic obstructive pulmonary disease
Source: Annual Congress 2008 - Allergy and immunology of asthma and beyond
Year: 2008

Fas Ligand (FasL) expressed on alveolar lymphocytes (AL) plays role in progression of interstitial lung diseases (ILD) but not in local induction of immune cells apoptosis
Source: Eur Respir J 2005; 26: Suppl. 49, 542s
Year: 2005

The death receptors (DRs) expressed on alveolar lymphocytes (AL) in interstitial lung diseases (ILD) participate in apoptosis regulation
Source: Annual Congress 2012 - Diffuse parenchymal lung disease pathogenesis, biomarkers, therapy and new entities
Year: 2012

Dendritic cell subsets in the lung: implication for allergic asthma
Source: Annual Congress 2006 - A new look at dendritic cell interactions in the lung
Year: 2006


Transcriptomic profiling of alveolar type 2 cells from mice expressing an ILD associated SFTPCI73T mutation supports their role in inflammatory cell recruitment and fibrotic lung remodeling.
Source: International Congress 2018 – Pulmonary fibrosis: from models to patients
Year: 2018